Cleopatra Hospital Co (CAI:CLHO) EBIT: E£1,472 Mil (TTM As of Mar. 2026)


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
88 GF Score
Price E£17.00
GF Value E£13.81
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co EBIT?

Cleopatra Hospital Co CAI:CLHO +3.66% 88 EBIT is E£1,472 Mil as of Mar. 2026. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.81 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Cleopatra Hospital Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was E£290 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was E£1,472 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cleopatra Hospital Co's annualized ROC % for the quarter that ended in Mar. 2026 was 8.00%. Cleopatra Hospital Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.77%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cleopatra Hospital Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.21%.


Cleopatra Hospital Co  (CAI:CLHO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cleopatra Hospital Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1156.044 * ( 1 - 30.25% )/( (9771.39 + 10381.933)/ 2 )
=806.34069/10076.6615
=8.00 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10241.259 - 1416.86 - ( 547.543 - max(0, 3310.317 - 2363.326+547.543))
=9771.39

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10984.689 - 1622.711 - ( 749.579 - max(0, 3825.35 - 2805.395+749.579))
=10381.933

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Cleopatra Hospital Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1160.876/( ( (7205.844 + max(-891.718, 0)) + (7516.454 + max(-773.155, 0)) )/ 2 )
=1160.876/( ( 7205.844 + 7516.454 )/ 2 )
=1160.876/7361.149
=15.77 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1241.456 + 281.335 + 0) - (1416.86 + 0 + 997.649)
=-891.718

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1445.453 + 317.92 + 256.566) - (1622.711 + 0 + 1170.383)
=-773.155

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cleopatra Hospital Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=1472.282/28257.572
=5.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleopatra Hospital Co EBIT Related Terms


Cleopatra Hospital Co EBIT Historical Data

* Premium members only.

The historical data trend for Cleopatra Hospital Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleopatra Hospital Co EBIT Chart

Cleopatra Hospital Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 569.06 487.33 679.37 1,205.71 1,546.42

Cleopatra Hospital Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.36 444.39 477.84 259.83 290.22

CAI:CLHO vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Cleopatra Hospital Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleopatra Hospital Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cleopatra Hospital Co's EV-to-EBIT falls into.


CAI:CLHO
88GF Score
Cleopatra Hospital Co CAI:CLHO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleopatra Hospital Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£1,472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of E£1,472 Mil mean?
Cleopatra Hospital Co (CAI:CLHO) has a EBIT of E£1,472 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cleopatra Hospital Co.
Is Cleopatra Hospital Co's EBIT too high?
Cleopatra Hospital Co's current EBIT is E£1,472 Mil. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's EBIT compare to HCA and THC?
Cleopatra Hospital Co's EBIT of E£1,472 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cleopatra Hospital Co. Cleopatra Hospital Co's current EBIT is E£1,472 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.81, compared to a current price of E£17.00 — trading 23.1% above its estimated fair value. The current EBIT is E£1,472 Mil. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current EBIT is E£1,472 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£17.00 is trading 23.1% above its estimated GF Value™ of E£13.81. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • EBIT: E£1,472 Mil
  • GF Value™: E£13.81 vs. price of E£17.00 (23.1% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score

Get the complete analysis for CAI:CLHO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£17.00
Price
E£13.81
GF Value